Roles of microbiota-mediated hepatocarcinogenesis
微生物介导的肝癌发生的作用
基本信息
- 批准号:10702289
- 负责人:
- 金额:$ 25.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdenovirusesAnimal ModelAntigen PresentationAntiviral ResponseAreaB-LymphocytesBinding ProteinsCell DeathCentrosomeChromosomal InstabilityChronicComplexDevelopmentDockingEtiologyGene ExpressionGenesGenomic InstabilityGoalsHepatitisHepatitis B VirusHepatitis CHepatitis C virusHepatitis Delta VirusHepatocarcinogenesisHepatocyteHomeostasisHumanImmunityInflammationInterferonsLinkLiverMediatingMitosisMitotic spindleMolecularMolecular ProfilingNatural regenerationNuclear ExportOncogenicPathogenesisPathway interactionsPatientsPilot ProjectsPlayPrimary carcinoma of the liver cellsProteinsResearchRoleSamplingSignal TransductionTissuesViral PhysiologyViral ProteinsViral hepatitisVirusVirus Diseasescarcinogenesischronic liver diseasemicrobiotanovelnucleocytoplasmic transportnucleophosminpreventran-binding protein 1toolvirus core
项目摘要
Our previous results indicate that HBx contains a functional nuclear export signal motif that utilizes the Ran/Crm1 complex, a component essential in nucleocytoplasmic transport of many cellular and viral proteins. We demonstrated that HBx not only uses but also disrupts Ran/Crm1-dependent activities, presumably to prevent a host antiviral response. This finding implicates the Ran/Crm1 complex in the molecular pathogenesis of hepatitis B virus. Recently, we uncovered a new role of the Ran/Crm1 complex in regulating cellular proteins that control centrosome duplication and mitotic spindle assembly. We revealed nucleophosmin as a novel substrate for Ran/Crm1 to negatively regulate unnecessary centrosome duplication. In addition, we demonstrated a hepatitis B virus / HBx -dependent activation of RanBP1, a Ran-binding protein that is known to destabilize the Ran/Crm1 complex. Elevated RanBP1 is also observed in positive liver tissues and in hepatocellular carcinoma. Increased expression of RanBP1 leads to multipolar spindles and abnormal mitoses. Thus, the combined effects of hepatitis B virus / HBx contribute to chromosome instability. These findings led us to generate a new hypothesis in which the Ran/Crm1 complex serves as the centrosome duplication checkpoint by providing a loading dock mechanism that controls cellular homeostasis, and the disruption of this complex may result in genomic instability, which may be an early step in viral hepatitis-mediated hepatocarcinogenesis. In addition to HBx, recently we have completed a pilot study by determining hepatitis C virus core-related gene expression profiles in B lymphocytes. We found that hepatitis C virus core may evict immunity by selectively suppressing genes involved in antigen presentation. These studies are useful in dissecting viral activities that are essential in hepatocarcinogenesis. Furthermore, we have conducted molecular profiling studies to compare the gene expression changes in primary human hepatocytes infected with adenoviruses harboring HBx or hepatitis C virus structural or non-structural genes (p21CORE, NS3 or NS5A). We also compared these gene expression profiles to those obtained from hepatitis C virus -infected liver samples from chronic liver disease patients and hepatitis C virus -related hepatocellular carcinoma. We found that hepatitis C virus -related proteins largely induce unique genes when compared to HBx. In particular, interferon-inducible gene 27 was highly expressed in hepatitis C virus or core infected hepatocytes and hepatitis C virus -related chronic liver disease or hepatocellular carcinoma, but was less significantly expressed in HBx infected hepatocytes or hepatitis B virus-related chronic liver disease or hepatocellular carcinoma, indicating that interferon-inducible gene 27 may play a role in hepatitis C virus -mediated hepatocellular carcinoma. In conclusion, our results suggest that hepatitis B virus and hepatitis C virus promote hepatocellular carcinoma development mainly through different mechanisms.
我们之前的结果表明,HBx 含有一个功能性核输出信号基序,该基序利用 Ran/Crm1 复合物,这是许多细胞和病毒蛋白核质运输中必需的成分。我们证明 HBx 不仅使用而且破坏 Ran/Crm1 依赖性活性,大概是为了阻止宿主抗病毒反应。这一发现表明 Ran/Crm1 复合物与乙型肝炎病毒的分子发病机制有关。最近,我们发现了 Ran/Crm1 复合物在调节控制中心体复制和有丝分裂纺锤体组装的细胞蛋白中的新作用。我们发现核磷蛋白是 Ran/Crm1 的一种新底物,可以负向调节不必要的中心体复制。此外,我们还证明了 RanBP1 的乙型肝炎病毒/HBx 依赖性激活,RanBP1 是一种 Ran 结合蛋白,已知会破坏 Ran/Crm1 复合物的稳定性。在阳性肝组织和肝细胞癌中也观察到 RanBP1 升高。 RanBP1 表达增加会导致多极纺锤体和异常有丝分裂。因此,乙型肝炎病毒/HBx 的综合作用导致染色体不稳定。这些发现使我们产生了一个新的假设,其中Ran/Crm1复合物通过提供控制细胞稳态的装载平台机制来充当中心体复制检查点,并且该复合物的破坏可能导致基因组不稳定,这可能是早期的病毒性肝炎介导的肝癌发生的一步。除了 HBx 之外,最近我们还完成了一项试点研究,确定 B 淋巴细胞中丙型肝炎病毒核心相关基因的表达谱。我们发现丙型肝炎病毒核心可能通过选择性抑制参与抗原呈递的基因来消除免疫力。这些研究有助于剖析肝癌发生中必需的病毒活性。此外,我们还进行了分子谱研究,以比较感染含有 HBx 或丙型肝炎病毒结构或非结构基因(p21CORE、NS3 或 NS5A)的腺病毒的原代人肝细胞中的基因表达变化。 我们还将这些基因表达谱与从慢性肝病患者和丙型肝炎病毒相关肝细胞癌的丙型肝炎病毒感染的肝脏样本中获得的基因表达谱进行了比较。我们发现,与 HBx 相比,丙型肝炎病毒相关蛋白在很大程度上诱导独特的基因。特别是,干扰素诱导基因27在丙型肝炎病毒或核心感染的肝细胞以及丙型肝炎病毒相关的慢性肝病或肝细胞癌中高表达,但在HBx感染的肝细胞或乙型肝炎病毒相关的慢性肝病中表达不太显着。或肝细胞癌,表明干扰素诱导基因27可能在丙型肝炎病毒介导的肝细胞癌中发挥作用。总之,我们的结果表明乙型肝炎病毒和丙型肝炎病毒主要通过不同的机制促进肝细胞癌的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xin Wei Wang其他文献
Xin Wei Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xin Wei Wang', 18)}}的其他基金
Viral exposure signatures may define individuals vulnerable for COVID-19
病毒暴露特征可能会定义个体是否容易感染 COVID-19
- 批准号:
10702767 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
Molecular signatures for liver cancer diagnosis and treatment stratification
肝癌诊断和治疗分层的分子特征
- 批准号:
10262066 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
Molecular signatures for liver cancer diagnosis and treatment stratification
肝癌诊断和治疗分层的分子特征
- 批准号:
10702334 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
The identification of human hepatocellular carcinoma metastasis genes
人肝癌转移基因的鉴定
- 批准号:
10926086 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
Mechanism of viral hepatitis-mediated hepatocarcinogenesis
病毒性肝炎介导的肝癌发生机制
- 批准号:
10262018 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
The identification of human hepatocellular carcinoma metastasis genes
人肝癌转移基因的鉴定
- 批准号:
10262174 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
癌症干细胞在肝癌异质性和亚型中的作用
- 批准号:
10262173 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
Identification of viral exposure signatures for early detection of liver cancer
鉴定病毒暴露特征以早期发现肝癌
- 批准号:
10703084 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
Viral exposure signatures may define individuals vulnerable for COVID-19
病毒暴露特征可能会定义个体是否容易感染 COVID-19
- 批准号:
10262566 - 财政年份:
- 资助金额:
$ 25.47万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the interplay of interferon-gamma and cathepsin S in age-related dry eye
定义干扰素-γ 和组织蛋白酶 S 在年龄相关性干眼症中的相互作用
- 批准号:
10483119 - 财政年份:2020
- 资助金额:
$ 25.47万 - 项目类别:
Defining the interplay of interferon-gamma and cathepsin S in age-related dry eye
定义干扰素-γ 和组织蛋白酶 S 在年龄相关性干眼症中的相互作用
- 批准号:
10231017 - 财政年份:2020
- 资助金额:
$ 25.47万 - 项目类别:
Defining the interplay of interferon-gamma and cathepsin S in age-related dry eye
定义干扰素-γ 和组织蛋白酶 S 在年龄相关性干眼症中的相互作用
- 批准号:
10703450 - 财政年份:2020
- 资助金额:
$ 25.47万 - 项目类别: